Anglican: Bupivacaine approved

Announcement from Onglicon: Recently, the company has received the "Approval Notice for the Application for Marketing Authorization of Chemical Raw Materials" issued by the National Medical Products Administration. The chemical raw material is called Bupivacaine, with registration number Y20230001273. The company submitted the drug registration application for Bupivacaine raw materials in December 2023, which was accepted in January 2024 and approved by the National Medical Products Administration recently. Bupivacaine formulations are mainly used for local anesthesia and postoperative pain relief in clinical practice. This approval notice for the marketing authorization of the chemical raw material Bupivacaine will further enrich the company's product line and enhance its core competitiveness.